CRISPR/Cas9-mediated Activation of Endogenous Ribosome-binding Protein 1 (RRBP1) in the Ischemic Heart in Vivo
| Institution | Ruprecht-Karls-Universität Heidelberg |
|---|---|
| Project leader | Shirin Doroudgar |
| Site | Heidelberg/Mannheim |
| Project type | Shared Expertise (SE) |
| Funding | € 36.800,00 |
| Begin | 01.01.2020 |
| End | 31.07.2021 |
| Partnerprojekte |
Förderkennzeichen
81X2500188
Projektnummer
1159